| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S101560100019 |
| P698 | PubMed publication ID | 11455503 |
| P2093 | author name string | Wang F | |
| Zhang YY | |||
| Zhu DM | |||
| Hu FP | |||
| P433 | issue | 2 | |
| P304 | page(s) | 117-120 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Journal of Infection and Chemotherapy | Q15756830 |
| P1476 | title | Surveillance of bacterial resistance among isolates in Shanghai in 1999. | |
| P478 | volume | 7 |
| Q38045609 | Antibiotic resistance amongst healthcare-associated pathogens in China. |
| Q42650135 | Burden of bacterial upper respiratory tract pathogens in school children of Nepal |
| Q33593668 | Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec |
| Q46862305 | Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase |
| Q37365772 | Global resistance trends and the potential impact on empirical therapy |
| Q50723093 | In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus. |
| Q33418451 | Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis |
| Q38097374 | Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials |
| Q35102456 | Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China |
| Q34881142 | Rational antibiotic use in China: lessons learnt through introducing surgeons to Australian guidelines |
| Q37380390 | Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia |
| Q34618696 | The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections |
Search more.